Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Bionik Laboratories Corp. from 30 Sep 2022 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Sep 2022 to 31 Mar 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Mar 2023 was $73,353.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $73,353 31 Mar 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 $77,288 31 Dec 2022 10-Q 08 Feb 2023 2023 Q3
Q3 2022 $81,950 30 Sep 2022 10-Q 09 Nov 2022 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.